EUVIMEDAvasta EUVIMED
Crossref

Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6 /Axl Signaling Pathway

Aizhen Zhao, Wangrui Lei, Jiayin Tian, Xiaopeng Wu, Mengyu Li, Yan Zhang, Xue Wu, Xuezeng Xu, Jiayou Tang, Yang Yang iD, Zhenxiao Jin

Phytotherapy Research · 2025-03 · 39 (3) · 1388-1402

DOI: 10.1002/ptr.8423 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2025-01-09. Written by Aizhen Zhao and 10 co-authors. Institution: Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences and Medicine, Northwest Univer…. Major MEDLINE topics: Xanthones, Signal Transduction, Myocardial Reperfusion Injury, Intercellular Signaling Peptides and Proteins. Cited 4 times so far (Crossref); 35 references. Funded by: Wellcome Trust, Qinchuangyuan Traditional Chinese Medicine Innovation Research and Development Transformation Project, Research Plan Project of Shaanxi Institute of Basic Science.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Ischemia reperfusion‐induced myocardial injury is a prominent pathological feature in patients with coronary artery disease, contributing to significant mortality and morbidity rates. Mangiferin (MGF), the main active ingredient extracted from Anemarrhena asphodeloides Bge , has anti‐inflammatory, anti‐oxidation, anti‐diabetes, and anti‐tumor effects. The present study confirmed that the GAS6/Axl pathway was identified as a promising novel target for the treatment of myocardial ischemia reperfusion (IR) injury. However, whether MGF exerts anti‐myocardial ischemia reperfusion injury through GAS6/Axl is still unclear. In this study, BALB/c male mice and HL‐1 cardiomyocytes were used to construct a model of IR and hypoxia‐reoxygenation (HR) (or H 2 O 2 ) injury in vivo and in vitro, respectively. MGF significantly improved cardiac function indicators, myocardial structure, myocardial enzymes, and mitochondrial function, together with reduced oxidative stress and apoptosis in IR‐injured mice. In vitro, MGF significantly increased cell viability, inhibited the release of LDH, reduced oxidative stress and apoptosis, and improved mitochondrial function in both HR and H 2 O 2 ‐injured HL‐1 cells. In particular, the GAS6/Axl signaling pathway plays an important role in this process. Additionally, we also demonstrated that GAS6 gene knockout reversed the protective effect of MGF against HR and H 2 O 2 ‐injured cardiomyocytes. The present study confirmed that MGF has protective effects against myocardial IR injury by activating the GAS6/Axl pathway, providing a theoretical basis for MGF as a potential cardioprotective drug in the clinical setting of myocardial IR injury.

Subjects

MeSH terms (MEDLINE)

XanthonesSignal TransductionMyocardial Reperfusion InjuryIntercellular Signaling Peptides and ProteinsProto-Oncogene ProteinsAnimalsMaleMiceMyocytes, CardiacApoptosisMice, Inbred BALB COxidative StressCell LineCell SurvivalGrowth Arrest-Specific Protein 6

Author keywords

AxlGAS6Mangiferincardioprotectivemyocardial ischemia reperfusion injury

Substances

XanthonesIntercellular Signaling Peptides and ProteinsProto-Oncogene ProteinsGrowth Arrest-Specific Protein 6mangiferin

Authors and institutions

  • Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences and Medicine, Northwest University, Xi'an, China.
  • Xi'an Key Laboratory of Innovative Drug Research for Heart Failure, Northwest University First Hospital, Northwest University, Xi'an, China.
  • Department of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.

ORCID profiles: Yang Yang

Funding

  • Wellcome Trust
  • Qinchuangyuan Traditional Chinese Medicine Innovation Research and Development Transformation Project
  • Research Plan Project of Shaanxi Institute of Basic Science
  • Key Medical Research Projects in Xi'an City
  • National Natural Science Foundation of China
  • Shaanxi Province Traditional Chinese Medicine Research and Innovation Talent Project

Cite

APA

Zhao, A., Lei, W., Tian, J., Wu, X., Li, M., Zhang, Y., Wu, X., Xu, X., Tang, J., Yang, Y., & Jin, Z. (2025). Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6 /Axl Signaling Pathway. Phytotherapy Research, 39(3), 1388-1402. https://doi.org/10.1002/ptr.8423

Vancouver

Zhao A, Lei W, Tian J, Wu X, Li M, Zhang Y, et al. Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6 /Axl Signaling Pathway. Phytotherapy Research. 2025;39(3):1388-1402. doi:10.1002/ptr.8423

BibTeX
@article{Zhao2025,
  author = {Zhao, Aizhen and Lei, Wangrui and Tian, Jiayin and Wu, Xiaopeng and Li, Mengyu and Zhang, Yan and Wu, Xue and Xu, Xuezeng and Tang, Jiayou and Yang, Yang and Jin, Zhenxiao},
  title = {Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6 /Axl Signaling Pathway},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {1388--1402},
  doi = {10.1002/ptr.8423}
}
Start for free →